These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 34287815)
1. Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review. Nishizawa K; Yamashita T; Ogawa Y; Kobayashi H CEN Case Rep; 2022 Feb; 11(1):43-49. PubMed ID: 34287815 [TBL] [Abstract][Full Text] [Related]
2. Successful treatment of coexisting membranous nephropathy and immune thrombocytopenia by eradicating gastric Helicobacter pylori infection: a case report. Suetsugu R; Sakuma H; Maruyama K; Matsuki M; Ogawa Y; Nakagawa N CEN Case Rep; 2024 Apr; 13(2):98-103. PubMed ID: 37421572 [TBL] [Abstract][Full Text] [Related]
13. Malignancy-associated membranous nephropathy with PLA2R double-positive for glomeruli and carcinoma. Yasuda I; Tokuyama H; Hashiguchi A; Hasegawa K; Uchiyama K; Ryuzaki M; Yasuda M; Mizuno R; Ishidoya S; Wakino S; Itoh H CEN Case Rep; 2021 May; 10(2):281-286. PubMed ID: 33393071 [TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176 [TBL] [Abstract][Full Text] [Related]
15. Circulating antibodies to α-enolase and phospholipase A Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547 [TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy. Sato Y; Tsunoda S; Nozue T; Pan Q; Wakasugi H; Yoshimura A Intern Med; 2012; 51(18):2597-602. PubMed ID: 22989833 [TBL] [Abstract][Full Text] [Related]
17. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy. Rashid RM; Nabi Z; Ansari AZ; Qaiser QA BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892 [TBL] [Abstract][Full Text] [Related]
18. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555 [TBL] [Abstract][Full Text] [Related]
19. Effects of phospholipase A Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents. Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]